While the world struggled with the spread of the corona virus and the new mutation in the corona virus, Uneth Sahin CEO and founder Ughar Sahin said the deadly virus would stay with us for at least the next decade. routine. The virus will stay with us for the next ten years, “he said.
Read more in Calcalist
The Biontech vaccine, developed in collaboration with US pharmaceutical giant Pfizer, has so far been approved for use in more than 45 countries, including the UK and US. Sahin also said the vaccine could be adapted to the new British mutation in about six weeks. “It is possible to start directly engineering a new vaccine that completely mimics the new mutation, and it is possible to start delivering it within six weeks.”
Sahin said he was confident the new mutation would not affect the vaccine’s effectiveness. The corona’s new mutation is causing worldwide concern, but its full effects are still unknown. Following its discovery, UK Health Minister Matt Hancock said the mutation had been linked to travelers returning from South Africa. “The new mutation is very worrying because it passes more easily and seems to have undergone more mutations since it was discovered in the UK,” he said.
On December 19, British Prime Minister Boris Johnson said the first mutation of Cubid 19 was discovered, which is 70% more contagious. He subsequently imposed traffic restrictions on London and other parts of England. The British mutation spreads more easily in children as well. It was discovered following a spike in morbidity in the UK earlier this month, but is estimated to have been spreading since September. Due to the spread of the mutation in the UK, the government announced last weekend a series of new restrictions that will be in force at Christmas.
Meanwhile, the American pharmaceutical company Modern said on Tuesday that it believes that the vaccine it has developed against the corona virus will also be effective against the mutation, but stated that it intends to conduct experiments to confirm this. “Based on the data we have collected so far, Moderna estimates that the immune response to Moderna’s vaccine will protect against various mutations of the virus recently discovered in the UK,” the US company said in a statement. “We will conduct further trials for the vaccine in the coming weeks to confirm this.”